327 related articles for article (PubMed ID: 33259649)
1. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
[TBL] [Abstract][Full Text] [Related]
3. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
[TBL] [Abstract][Full Text] [Related]
4. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.
Choi J; Laws A; Hu J; Barry W; Golshan M; King T
Ann Surg Oncol; 2018 Nov; 25(12):3541-3547. PubMed ID: 30128902
[TBL] [Abstract][Full Text] [Related]
5. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
[TBL] [Abstract][Full Text] [Related]
6. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
Pilewskie M; Zabor EC; Mamtani A; Barrio AV; Stempel M; Morrow M
Ann Surg Oncol; 2017 Nov; 24(12):3527-3533. PubMed ID: 28762114
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
[TBL] [Abstract][Full Text] [Related]
8. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
[TBL] [Abstract][Full Text] [Related]
9. Management of positive margins after initial lumpectomy in elderly women with breast cancer.
Angarita FA; Acuna SA; McCready DR; Escallon J
Eur J Surg Oncol; 2018 Jul; 44(7):1048-1053. PubMed ID: 29525464
[TBL] [Abstract][Full Text] [Related]
10. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
11. The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.
Mazouni C; Naveau A; Kane A; Dunant A; Garbay JR; Leymarie N; Sarfati B; Delaloge S; Rimareix F
Breast; 2013 Dec; 22(6):1189-93. PubMed ID: 24054903
[TBL] [Abstract][Full Text] [Related]
12. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
[TBL] [Abstract][Full Text] [Related]
13. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.
Rubio IT; Esgueva-Colmenarejo A; Espinosa-Bravo M; Salazar JP; Miranda I; Peg V
Ann Surg Oncol; 2016 Jan; 23(1):38-43. PubMed ID: 26514120
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy.
Davoine E; Dion L; Nyangoh Timoh K; Beraud E; Tas P; Tavenard A; Laviolle B; Perrin C; Foucher F; Levêque J; Lavoué V
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):467-472. PubMed ID: 31207391
[TBL] [Abstract][Full Text] [Related]
16. Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
Cen C; Chun J; Kaplowitz E; Axelrod D; Shapiro R; Guth A; Schnabel F
Ann Surg Oncol; 2021 Sep; 28(9):5142-5148. PubMed ID: 33635409
[TBL] [Abstract][Full Text] [Related]
17. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
18. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
19. Short term safety of oncoplastic breast conserving surgery for larger tumors.
Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
[TBL] [Abstract][Full Text] [Related]
20. Opportunities to reduce reoperations and to improve inter-facility profiling after initial breast-conserving surgery for cancer. A report from the NCDB.
Landercasper J; Bennie B; Ahmad HF; Linebarger JH
Eur J Surg Oncol; 2019 Nov; 45(11):2026-2036. PubMed ID: 31383386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]